Skip to main content
SpringerLink
Log in

Do Standardized Beta-Blocker Titration Protocols in Heart Failure Improve Compliance? The GESICA Registry Experience

  • Editorial
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Remme WJ, Swedberg K, for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527–1560.

    Google Scholar 

  2. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines) J Am Coll Cardiol 2001;38:2101–2113.

    Google Scholar 

  3. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349–1355

    Google Scholar 

  4. CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9–13.

    Google Scholar 

  5. Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001–2007.

    Google Scholar 

  6. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651–1658.

    Google Scholar 

  7. Poole-Wilson PA, Swedberg K, Cleland JGF, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial. Lancet 2003;362:7–13.

    Google Scholar 

  8. Hobbs FDR, Jones MI, Allan TF, Wilson S, Tobias R. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J 2000;21:1877–1887.

    Google Scholar 

  9. Cleland JG, Cohen-Solal A, Cosin Aguilar J, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): An international survey. Lancet 2002;360:1631–1639.

    Google Scholar 

  10. Remme WJ, Boccanelli A, Cline C, et al. Increasing awareness and perception of heart failure in Europe and improving care—Rationale and design of the SHAPE study. Cardiovasc Drugs Ther 2004;18:153–159.

    Google Scholar 

  11. Remme WJ, Cline C, Cohen Solal A, et al. Inadequate perception of heart failure is associated with underuse of diagnostic and therapeutic strategies in heart failure by the primary care physician: Results from SHAPE, a major European survey. J Am Coll Cardiol 2004;43(suppl. A): 222A.

    Google Scholar 

  12. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe. Eur Heart J 2003;24:464–475.

    Google Scholar 

  13. Nul D, Zambrano C, Ferrante D, et al. Impact of a standardized titration protocol with carvedilol in heart failure: Safety, tolerability and efficacy—a report from the Gesica registry. Cardiovasc Drugs Ther 2005;19:125–134.

    Google Scholar 

  14. Maggioni AP, Sinagra G, Opasisch C, et al. Treatment of chronic heart failure with β-adrenergic blockade beyond controlled clinical trials: The BRING-UP experience. Heart 2003;89:299–305.

    Google Scholar 

  15. Deedwania PC, Gottlieb S, Ghali JK, et al. Efficacy, safety and tolerability of b-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 2004;25:1300–1309.

    Google Scholar 

  16. Rouleau JL, Roecker EB, Tendera M, et al. Influence of pre-treatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure. J Am Coll Cardiol 2004;43:1423–1429.

    Google Scholar 

  17. Kotlyar E, Keoch AM, Macdonald PS, Arnold RH, McCaffrey DJ, Glanvill AR. tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant 2002;12:1290–1295.

    Google Scholar 

  18. Gattis WA, Oçonnor CM, Gallup DS, Hasselblad VF, Gheorhiade M on behalf of the IMPACT-HF investigators. J Am Coll Cardiol 2004;43:1534–1541.

    Google Scholar 

Download references

Authors
  1. Willem J. Remme
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Remme, W.J. Do Standardized Beta-Blocker Titration Protocols in Heart Failure Improve Compliance? The GESICA Registry Experience. Cardiovasc Drugs Ther 19, 99–101 (2005). https://doi.org/10.1007/s10557-005-3404-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-005-3404-5

Keywords

Search

Navigation